Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 24 results.
User Information
Export Records
  1. 1.   Characterization of and isolation methods for plant leaf nanovesicles and small extracellular vesicles
  2. Liu, Yuan; Wu, Sherry; Koo, Yeonjong; Yang, An; Dai, Yanwan; Khant,Htet; Osman, Samantha; Chowdhury, Mamur; Wei, Haichao; Li, Yang; Court, Karem; Hwang, Elaine; Wen, Yunfei; Dasari, Santosh Kumar; Nguyen, Michael; Tang, E Chia-Cheng; Chehab, E Wassim; De Val Alda,Natalia; Braam, Janet; Sood, Anil K
  3. Nanomedicine : nanotechnology, biology, and medicine. 2020, OCT; 29: 102271.
  1. 2.   Peptide Mediated Intracellular Delivery of Semiconductor Quantum Dots
  2. Kapur, Anshika; Safi, Malak; Domitrovic, Tatiana; Medina, Scott; Palui, Goutam; Johnson, John E.; Schneider, Joel; Mattoussi, Hedi; Osinski, M; Parak, WJ; Liang, XJ
  3. COLLOIDAL NANOPARTICLES FOR BIOMEDICAL APPLICATIONS XII (Book Series: Proceedings of SPIE). 2017, JAN 28-31; 10078 Article Number: UNSP 100780S .
  1. 3.   A Randomized Controlled Trial to Evaluate the Effectiveness of a Board Game on Patients' Knowledge Uptake of HIV and Sexually Transmitted Diseases at the Infectious Diseases Institute, Kampala, Uganda
  2. Wanyama, J. N.; Castelnuovo, B.; Robertson, G.; Newell, K.; Sempa, J. B.; Kambugu, A.; Manabe, Y. C.; Colebunders, R.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2012, Mar; 59(3): 253-258.
  1. 4.   Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro
  2. Franca, A.; Aggarwal, P.; Barsov, E. V.; Kozlov, S. V.; Dobrovolskaia, M. A.; Gonzalez-Fern, ez
  3. Nanomedicine. 2011, Sep; 6(7): 1175-1188.
  1. 5.   New Nanosized Biocompatible MR Contrast Agents Based on Lysine-Dendri-Graft Macromolecules
  2. Ogawa, M.; Regino, C. A. S.; Marcelino, B.; Williams, M.; Kosaka, N.; Bryant, L. H.; Choyke, P. L.; Kobayashi, H.
  3. Bioconjugate Chemistry. 2010, May; 21(5): 955-960.
  1. 6.   Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution
  2. Dobrovolskaia, M. A.; Aggarwal, P.; Hall, J. B.; McNeil, S. E.
  3. Molecular Pharmaceutics. 2008 5(4): 487-495.
  1. 7.   Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1
  2. Sabado, R. L.; Babcock, E.; Kavanagh, D. G.; Tjomsl, V.; Walker, B. D.; Lifson, J. D.; Bhardwaj, N.; Larsson, M.
  3. European Journal of Immunology. 2007, Jul; 37(7): 1752-1763.
  1. 8.   Induction of the formyl peptide receptor 2 in microglia by IFN-gamma and synergy with CD40 ligand
  2. Chen, K. Q.; Iribarren, P.; Huang, J.; Zhang, L. Z.; Gong, W. H.; Cho, E. H.; Lockett, S.; Dunlop, N. M.; Wang, J. M.
  3. Journal of Immunology. 2007, Feb; 178(3): 1759-1766.
  1. 9.   Activation of toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide
  2. Chen, K. Q.; Iribarren, P.; Hu, J. Y.; Chen, J. H.; Gong, W. H.; Cho, E. H.; Lockett, S.; Dunlop, N. M.; Wang, J. M.
  3. Journal of Biological Chemistry. 2006, FEB 10; 281(6): 3651-3659.
  1. 10.   Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Trivett, M.; Williams, M.; Wu, L.; KewalRamani, V. N.; Pinto, L. A.
  3. European Journal of Immunology. 2006, Feb; 36(2): 437-445.
  1. 11.   CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2
  2. Iribarren, P.; Chen, K. Q.; Hu, J. Y.; Gong, W. H.; Cho, E. H.; Lockett, S.; Uranchimeg, B.; Wang, J. M.
  3. Faseb Journal. 2005, OCT; 19(12): Published as FJ Express article on October 11, 2005.
  1. 12.   Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis
  2. Lu, Z. X.; Ye, M.; Yan, G. R.; Li, Q.; Tang, M.; Lee, L. M.; Sun, L. Q.; Cao, Y.
  3. Cancer Gene Therapy. 2005, JUL; 12(7): 647-654.
  1. 13.   Global transcriptional programs reveal a carbon source foraging strategy by Escherichia coli
  2. Liu, M. Z.; Durfee, T.; Cabrera, J. E.; Zhao, K.; Jin, D. J.; Blattner, F. R.
  3. Journal of Biological Chemistry. 2005, APR 22; 280(16): 15921-15927.
  1. 14.   Preclinical manufacture of anti-HER2 liposome-inserting, scFv-PEG-Lipid conjugate. 2. Conjugate micelle identity, purity, stability, and potency analysis
  2. Nellis, D. F.; Giardina, S. L.; Janini, G. M.; Shenoy, S. R.; Marks, J. D.; Tsai, R.; Drummond, D. C.; Hong, K.; Park, J. W.; Ouellette, T. F.; Perkins, S. C.; Kirpotin, D. B.
  3. Biotechnology Progress. 2005, JAN-FEB; 21(1): 221-232.
  1. 15.   The development of VIP-ellipticine conjugates
  2. Moody, T. W.; Czerwinski, G.; Tarasova, N. I.; Moody, D. L.; Michejda, C. J.
  3. Regulatory Peptides. 2004, DEC 15; 123(1-3): 187-192.
  1. 16.   Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo
  2. Biragyn, A.; Ruffini, P. A.; Coscia, M.; Harvey, L. K.; Neelapu, S. S.; Baskar, S.; Wang, J. M.; Kwak, L. W.
  3. Blood. 2004, OCT 1; 104(7): 1961-1969.
  1. 17.   Ceramidase regulates synaptic vesicle exocytosis and trafficking
  2. Rohrbough, J.; Rushton, E.; Palanker, L.; Woodruff, E.; Matthies, H. J. G.; Acharya, U.; Acharya, J. K.; Broadie, K.
  3. Journal of Neuroscience. 2004, SEP 8; 24(36): 7789-7803.
  1. 18.   Cancer-specific ligands identified from screening of peptide-display libraries
  2. Mori, T.
  3. Current Pharmaceutical Design. 2004 10(19): 2335-2343.
  1. 19.   Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells
  2. Turville, S. G.; Santos, J. J.; Frank, I.; Cameron, P. U.; Wilkinson, J.; Miranda-Saksena, M.; Dable, J.; Stossel, H.; Romani, N.; Piatak, M.; Lifson, J. D.; Pope, M.; Cunningham, A. L.
  3. Blood. 2004 103(6): 2170-2179.
  1. 20.   Binding, internalization, and membrane incorporation of human immunodeficiency virus-1 at the blood-brain barrier is differentially regulated
  2. Banks, W. A.; Robinson, S. M.; Wolf, K. M.; Bess, J. W.; Arthur, L. O.
  3. Neuroscience. 2004 128(1): 143-153.
  1. 21.   Antitumor effects induced by dendritic cell-based immunotherapy against established pancreatic cancer in hamsters
  2. Akiyama, Y.; Maruyama, K.; Nara, N.; Hojo, T.; Cheng, J. Y.; Mori, T.; Wiltrout, R. H.; Yamaguchi, K.
  3. Cancer Letters. 2002, Oct 8; 184(1): 37-47.
  1. 22.   Intracellular localization of 7-benzylamino-6-chloro-2- piperazino-4-pyrrolidino-pteridine in membrane structures impeding the inhibition of cytosolic cyclic AMP-specific phosphodiesterase
  2. Marko, D.; Merz, K. H.; Kunz, C.; Muller, A.; Tarasova, N.; Eisenbr, G.
  3. Biochemical Pharmacology. 2002 63(4): 669-676.
  1. 23.   OxyR and SoxRS regulation of fur
  2. Zheng, M.; Doan, B.; Schneider, T. D.; Storz, G.
  3. Journal of Bacteriology. 1999 181(15): 4639-4643.
  1. 24.   Cationic Liposome-Mediated Uptake of Human Immunodeficiency Virus Type 1 Tat Protein Into Cells
  2. Fong, S. E.; Smanik, P.; Smith, M. C.; Jaskunas, S. R.
  3. Journal of Virological Methods. 1997 66(1): 149-157.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel